Curaleaf (OTCMKTS:CURLF) Shares Gap Down – Time to Sell?

Curaleaf Holdings, Inc. (OTCMKTS:CURLF) shares gapped down prior to trading on Monday . The stock had previously closed at $2.87, but opened at $2.65. Curaleaf shares last traded at $2.7080, with a volume of 101,701 shares traded.

Analysts Set New Price Targets

Several research firms recently issued reports on CURLF. ATB Capital raised shares of Curaleaf to an “outperform” rating in a report on Tuesday, December 2nd. Atb Cap Markets raised shares of Curaleaf from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, December 2nd. Alliance Global Partners restated a “buy” rating on shares of Curaleaf in a research note on Monday, December 22nd. Finally, Canaccord Genuity Group raised shares of Curaleaf to a “strong-buy” rating in a report on Thursday, October 9th. Two research analysts have rated the stock with a Strong Buy rating and two have assigned a Buy rating to the company’s stock. According to data from MarketBeat, Curaleaf has a consensus rating of “Strong Buy”.

Curaleaf Price Performance

The company has a quick ratio of 0.71, a current ratio of 1.47 and a debt-to-equity ratio of 0.96. The company has a market capitalization of $1.74 billion, a PE ratio of -8.03 and a beta of 0.77. The firm’s 50 day simple moving average is $2.71 and its 200 day simple moving average is $2.33.

Curaleaf (OTCMKTS:CURLF) last released its quarterly earnings results on Wednesday, November 5th. The company reported ($0.06) EPS for the quarter, topping analysts’ consensus estimates of ($0.07) by $0.01. Curaleaf had a negative net margin of 19.50% and a negative return on equity of 15.57%. As a group, research analysts anticipate that Curaleaf Holdings, Inc. will post -0.25 EPS for the current fiscal year.

Curaleaf Company Profile

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.